$108 Million is the total value of Euclidean Capital LLC's 10 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ME | 23ANDME HOLDING CO | $29,295,000 | +15.3% | 10,243,122 | 0.0% | 27.20% | +25.9% | |
| PMVP | PMV PHARMACEUTICALS INC | $27,809,000 | -16.5% | 2,336,909 | 0.0% | 25.82% | -8.8% | |
| FHTX | FOGHORN THERAPEUTICS INC | $10,822,000 | -36.9% | 1,261,261 | 0.0% | 10.05% | -31.1% | |
| RAPT | RAPT THERAPEUTICS INC | $10,416,000 | +31.8% | 432,900 | 0.0% | 9.67% | +43.9% | |
| NGM | NGM BIOPHARMACEUTICALS INC | $9,766,000 | +2.0% | 746,674 | 0.0% | 9.07% | +11.4% | |
| ALEC | ALECTOR INC | $9,279,000 | -6.9% | 980,894 | 0.0% | 8.61% | +1.6% | |
| FFBC | FIRST FINL BANCORP OH | $3,659,000 | +8.7% | 173,576 | 0.0% | 3.40% | +18.6% | |
| TENAYA THERAPEUTICS INC | $2,656,000 | -48.5% | 915,705 | 0.0% | 2.47% | -43.8% | ||
| ORIC | ORIC PHARMACEUTICALS INC | $2,392,000 | -28.6% | 747,550 | 0.0% | 2.22% | -22.0% | |
| SURROZEN INC | $1,622,000 | -32.7% | 802,963 | 0.0% | 1.51% | -26.5% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| PMV PHARMACEUTICALS INC | 12 | Q3 2023 | 54.4% |
| FOGHORN THERAPEUTICS INC | 12 | Q3 2023 | 16.4% |
| NGM BIOPHARMACEUTICALS INC | 12 | Q3 2023 | 14.5% |
| ALECTOR INC | 12 | Q3 2023 | 11.5% |
| RAPT THERAPEUTICS INC | 12 | Q3 2023 | 9.7% |
| ORIC PHARMACEUTICALS INC | 12 | Q3 2023 | 10.0% |
| TENAYA THERAPEUTICS INC | 9 | Q3 2023 | 9.9% |
| FIRST FINL BANCORP OH | 9 | Q4 2022 | 3.9% |
| SURROZEN INC | 9 | Q3 2023 | 2.9% |
| 23ANDME HOLDING CO | 7 | Q3 2023 | 27.2% |
View Euclidean Capital LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| PMV Pharmaceuticals, Inc. | February 14, 2022 | 2,336,909 | 5.1% |
View Euclidean Capital LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR/A | 2023-12-01 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
View Euclidean Capital LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.